Merkliste 
 1 Ergebnisse 
 
1

Phase II Study of Erlotinib as Third-line Monotherapy in Pa..:

Matsuura, S. ; Inui, N. ; Ozawa, Y....
Japanese Journal of Clinical Oncology.  41 (2011)  8 - p. 959-963 , 2011